Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Urine protein test"'
Autor:
Qurat Ul Ain Amjad, Spencer Ellis
Publikováno v:
Rheumatology Advances in Practice. 5
Case report - Introduction Antiphospholipid Syndrome (APS) is an autoimmune condition manifested by vascular thrombosis with or without pregnancy related morbidities. APS classification criteria require detection of persistent antibodies: Anti-Cardio
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims There is a general lack of scientific research on oxalate metabolism in primary glomerulonephritis (PGN) patients. The present study aimed to evaluate plasma oxalic acid (POx) concentration and urinary oxalate (UOx) excretion in P
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Reduction in proteinuria is associated with lower risk of end-stage kidney disease (ESKD) in IgA nephropathy (Thompson et al, 2019) and focal segmental glomerulosclerosis (FSGS) (Troost et al, 2017). Sparsentan, a dual endothelin
Autor:
Jonatan Barrera-Chimal, Alexandre Budu, Adriano Cleis Arruda, Ronaldo C. Araujo, Leandro Ceotto Freitas-Lima, Gabriel Rufino Estrela, Mauro Sérgio Perilhão
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Kinins plays a major role in immune response, where kinin B2 receptor is constitutively expressed and kinin B1 receptor is induced under inflammatory stimuli. Kinin B1 receptor deletion and blockage has been shown to have benefici
Autor:
Jeannette Lo, Jonathan Barratt, Suzanne Roy, Alan Glicklich, Cailin Sibley, Angelique Mittan, Colleen Stromatt, Aaron Endsley
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims IgA nephropathy (IgAN), the leading cause of primary glomerulonephritis, is an autoimmune disease with no approved treatments.1 Progression to end-stage-renal disease occurs in up to 45% of IgAN patients, requiring dialysis or kid
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims High blood pressure is a leading cause of end stage renal disease (ESRD). However; early detection of chronic kidney disease (CKD) delays progression of kidney failure and reduces the risk of cardiovascular complications. Therefor
Autor:
Arpita Arora, Venkatesan Sekhar, Anubhuti Chirkara, Bindu Kulshreshtha, Anamika Singh, Yadunandan Prasad Gupta, Tripti Khanna, Himansu Mahapatra, Parul Goyal
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Activation of RAS and tubulointerstitial damage might be seen in pre-albuminuria stage of diabetic nephropathy. Here, diagnostic tests of urinary Angiotensinogen, Cystatin C, Neutrophil gelatinase associated lipocalin and IL 18 ha
Autor:
Daniel Gaitan Roman, Alicia Moreno Ortiz, Rafael Del Pozo Alvarez, Dolores Martínez Esteban, Teresa Vazquez, Domingo Hernández
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Neprilysin inhibition (NEPi) combined with a renin-angiotensin system (RAS) blocker has been shown to play an important role among patients with heart failure (HF), whose main cause of inpatient admission is congestion, reducing e
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Tenofovir disoproxil fumarate (TDF), as the most common antiviral drug, can cause both proximal tubular transportation dysfunctions and eGFR decline. The relationship between them is not clear due to lack of clinical data from lar
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims The circulating anti-Phospholipase A2 receptor (PLA2R) antibody has been widely detected since its discovery in 2009. It was suggested that the cut-off of serum PLA2R antibody (PLA2RsAb) should be reset at below 20 RU/mL to prove